Legal piperazine-containing party pills - a new trend in substance misuse

被引:30
作者
Sheridan, Janie
Butler, Rachael
Wilkins, Chris
Russell, Bruce
机构
[1] Univ Auckland, Sch Pharm, Fac Med & Hlth Sci, Auckland 1, New Zealand
[2] Massey Univ, Coll Humanities & Social Sci, Ctr Social & Hlth Outcomes Res & Evaluat, Palmerston North, New Zealand
关键词
D O I
10.1080/09595230701255791
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
In this Harm Reduction Digest Sheridan, Butler, Wilkins and Russell address the emergent phenomenon of so-called 'legal party pills' which have become a significant drug issue in New Zealand and elsewhere. Although banned in a number of countries, they are currently legally available in New Zealand where they are marketed as 'safe' alternatives' to 'illicit' drugs often used in the dance scene such as MDMA and amphetamines. The authors describe the availability and use of these substances in New Zealand, summarize what is known about their effects, and speculate on harm reduction interventions and mechanisms of control and their possible sequelae. The paper provides a timely account of an emerging drug issue of relevance to harm reduction internationally.
引用
收藏
页码:335 / 343
页数:9
相关论文
共 63 条
  • [21] Expert Advisory Committee on Drugs, 2006, FURTH EACD ADV BENZ
  • [22] Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users
    Falck, RS
    Carlson, RG
    Wang, JC
    Siegal, HA
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2004, 74 (01) : 45 - 54
  • [23] Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys
    Fantegrossi, WE
    Winger, G
    Woods, JH
    Woolverton, WL
    Coop, A
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2005, 77 (02) : 161 - 168
  • [24] GEE P, 2006, NZ MED J, V118, P1
  • [25] The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")
    Green, AR
    Mechan, AO
    Elliott, JM
    O'Shea, E
    Colado, MI
    [J]. PHARMACOLOGICAL REVIEWS, 2003, 55 (03) : 463 - 508
  • [26] GROTEWIEL MS, 1994, J PHARMACOL EXP THER, V271, P1122
  • [27] MECHANISTIC INVESTIGATION OF THE STIMULUS PROPERTIES OF 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE
    HERNDON, JL
    PIERSON, ME
    GLENNON, RA
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (03) : 739 - 748
  • [28] A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions
    Kelly, E
    Darke, S
    Ross, J
    [J]. DRUG AND ALCOHOL REVIEW, 2004, 23 (03) : 319 - 344
  • [29] MAGYAR K, 1987, POL J PHARMACOL PHAR, V39, P107
  • [30] MALOMVOLGYI B, 1991, ACTA PHYSIOL HUNG, V78, P201